Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Latest News

• ImmunoPrecise Accelerates the Launch of its European, Full-service, B-cell Facility
• IMMUNOPRECISE CLOSES PRIVATE PLACEMENT FINANCING
• IMMUNOPRECISE INCREASES PRIVATE PLACEMENT FINANCING
• IMMUNOPRECISE ANNOUNCES PRIVATE PLACEMENT FINANCING